IGC Pharma stockholders re-elect two directors, ratify auditor, approve 5M share grant

IGC Pharma, Inc.

Richard Prins (26,116,740 for) and Terry Lierman (27,800,503 for) re-elected as Class B directors until 2027.
Ratified Manohar Chowdhry & Associates as independent registered public accounting firm for 2025 fiscal year (42,587,128 for).
Approved grant of up to 5,000,000 common shares to employees, advisors, directors, and consultants.
Non-binding advisory vote indicates executive compensation votes will be held every three years.
Approximately 56.6% of outstanding shares (42,811,367) voted; 14,877,728 broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.